TY  - BOOK
AU  - WHO
TI  - HIV drug resistance Early warning indicators
AV  - WC503.2 W 46 2010 
PY  - 2010///
CY  - Geneva,Switzerland
PB  - (WHO)World Health Organization
KW  - Drugs|Art|Human immunodeficiency virus|Drug Resistance|Treatment
N1  - Describes the key element in the recommended HIV Drug Resistance prevention and assessment strategy by the WHO which includes: ART site based HIV Drug Resistance (HIVDR) Early Warning Indicators. Includes indicators such as ART prescribing practices, patients lost to follow-up 12 months after ART initiation, patients on appropriate first-line ART at 12 months, on-time ARV drug pick-up, ART clinic appointment keeping, ARV drug supply continuity, optional early warning indicators. Demonstrates how results can inform national decision-making on ART programme planning and other HIV drug resistance prevention measures
ER  -